Cannvas Retains Integral Wealth Securities Limited for Market Making

Integral will trade securities of Cannvas on the CSE for the purposes of maintaining an orderly market of Cannvas’ securities. In consideration of the services provided by Integral, Cannvas will pay Integral a monthly cash fee of $7,500. Integral will not receive shares or options as compensation. However, Integral and its clients may have or may acquire a direct interest in the securities of Cannvas.

Cannvas and Integral are unrelated and unaffiliated entities; Integral is a member of the Investment Industry Regulatory Organization of Canada (“IIROC”) and can access all Canadian Stock Exchange and Alternative Trading Systems. The capital and securities required for any trade undertaken by Integral as principal will be provided by Integral.  The agreement will have a minimum term of 12 months.  Following the 12-month anniversary of the agreement, Cannvas may terminate the agreement on 30 days notice.

About Integral Wealth Securities

Integral Wealth Securities Limited is a national, independent investment dealer that provides private and public issuers with investment banking services, institutional investors and public issuers with capital markets services and affluent individuals with wealth management services.  Founded in 2003, the firm has established capabilities in market making, energy banking, and private debt / equity.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: www.cannvasmedtech.com; Media Inquiries, media@cannvasmedtech.com; Investor Relations, ir@cannvasmedtech.com, 1-800-489-0116